Spinogenix
San Diego, United States· Est.
Spinogenix develops small molecule therapeutics targeting synaptic dysfunction to treat neurodegenerative diseases like ALS and Alzheimer's.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
Spinogenix develops small molecule therapeutics targeting synaptic dysfunction to treat neurodegenerative diseases like ALS and Alzheimer's.
NeuroscienceSmall Molecules